Boostrix (GlaxoSmithKline).
GlaxoSmithKline plc has developed and launched Boostrix, a subunit vaccine for use in adolescents and adults as a booster immunization against diphtheria, tetanus and pertussis (DTPa) infections.
Jones
Taff
T
ID Biomedical Corp of Quebec, Canada. tjones@idbiomedical.com
D000293:Adolescent; D000328:Adult; D002648:Child; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000737:chemistry / Q000276:immunology* / Q000493:pharmacokinetics / Q000633:toxicity; D006801:Humans; D007117:Immunization, Secondary; D013329:Structure-Activity Relationship
C505143:Boostrix; D015721:Diphtheria-Tetanus-Pertussis Vaccine